#USA #New York #Rosen Law Firm #POMDOCTOR #POM

Investors Have a Unique Opportunity with the PomDoctor Class Action Lawsuit

Overview

In a significant development for investors, the Rosen Law Firm, recognized globally for its excellence in investor rights, is encouraging those who purchased shares of PomDoctor Ltd. (NASDAQ: POM) between October 9, 2025 and December 11, 2025 to consider joining a class action lawsuit. This presents a crucial chance for affected investors to seek compensation for potential financial losses sustained due to alleged securities fraud.

Important Deadline Approach

Investors should be aware that a lead plaintiff deadline is fast approaching on April 7, 2026. To participate in this class action, individuals who fit the criteria must either submit a form through the Rosen Law Firm's website or contact attorney Phillip Kim for assistance. It is essential for interested parties to act swiftly, as this opportunity requires prompt action.

Class Action Participation

Joining the class action does not demand any upfront costs or out-of-pocket expenses, thanks to a contingency fee arrangement provided by the Rosen Law Firm. If you purchased PomDoctor securities within the specified class period, you may be eligible to share in any potential settlements resulting from the lawsuit.

Legal Representation

The law firm emphasizes the importance of choosing experienced legal counsel to represent investor interests. Rosen Law Firm has a proven track record of successful litigation in securities class actions, having secured substantial settlements for clients in the past, including records related to securities fraud against Chinese firms. Their expertise and recognition in the field make them a reliable choice for investors seeking to assert their rights in a complex legal landscape.

Allegations Against PomDoctor

The lawsuit centers on serious accusations against PomDoctor Ltd., claiming that misleading information and misinformation campaigns were orchestrated during the class period. Notably, it is alleged that:

1. Fraudulent Stock Promotion: PomDoctor was involved in deceptive stock promotion practices employing social media misinformation and financial professional impersonation.
2. Undisclosed Trading Activities: Insider activities included the use of offshore or nominee accounts to manipulate stock prices through coordinated share dumping.
3. Omission of Critical Information: Key public statements made by PomDoctor failed to disclose these activities and were potentially misleading, omitting critical risk disclosures.
4. Inflated Stock Price: Misrepresentation had led investors to believe in PomDoctor's business potential without transparency about the positions affecting stock valuation.

As a result, many investors may have been led to a false sense of security regarding the company’s performance and outlook, underlined by above discrepancies in public communications and real-time trading actions.

Next Steps for Investors

To facilitate the joining process of the PomDoctor class action lawsuit, investors can visit the Rosen Law Firm's webpage or contact legal representatives directly:

• - Phone: 866-767-3653 (toll-free)
• - Email: [email protected]

It’s worth noting that until a class is officially certified by the court, participants are advised to seek personal legal counsel and make informed decisions about their involvement. Moreover, being a lead plaintiff does not affect an investor's ability to receive potential compensation from the settlement.

Conclusion

The PomDoctor securities fraud class action presents a defining moment for affected investors to reclaim their rightful financial interests. With the guidance of specialized legal representation from the Rosen Law Firm, investors can navigate the complexities of securities fraud litigation with a higher chance for favorable outcomes. Don’t miss out on this opportunity; potential compensation awaits those who were misled during the class period.